We are live on
!
Find out more
AYLA
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
AYLA
Delisted
AYLA was delisted on the 18th of January, 2023.
12 hedge funds and large institutions have $20.7M invested in Ayala Pharmaceuticals, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
9% more funds holding
Funds holding: 11 → 12 (+1)
7% less capital invested
Capital invested by funds: $22.3M → $20.7M (-$1.65M)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCM
Sio Capital Management
New York
|
+$544K |
| 2 |
MWNA
Marshall Wace North America
New York
|
+$506K |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$240K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$107K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$44.6K |
Top Sellers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.18M |
| 2 |
Millennium Management
New York
|
-$135K |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$48.1K |
| 4 |
Morgan Stanley
New York
|
-$39.2K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$31.2K |
